Skip to main content
Equibles
NASC logo

NASC · Can B Corp

Track NASC — free

Use NASC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NASC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Nov 19, 2024

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt as to the Company's ability to continue as a going concern.”
View the 10-Q filed Nov 19, 2024
Market Cap
$758,419
Shares
75.84M
Volume · Nov 12 20K Avg daily vol (3M) 54.48K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.01 52W close$0.01–0.04 Avg vol 30d68K Short int2K · 0.0% of shares · 1.0d Short vol100% DataJan 2020–Nov 2026 Filing10-Q · Nov 19

Latest documents

2025
2024
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.03M
Trailing 12 months
Net income (TTM)
−$13.26M
Trailing 12 months
Revenue growth YoY
-96.4%
Year over year
Operating margin
-1,035.9%
Trailing 12 months
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 714.3%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$7,879
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+464.6%
Year over year · more shares
Price change (1Y)
-45.6%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg +4%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 16%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −25%
trailing
YTD return −30%
this year
Relative strength −27%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of shares out · ▼ -96.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1 holders — 13F breadth
Squeeze score 17
low risk · 0–100
Fundamentals
Strong
Revenue growth +29%
Y/Y
Gross margin 292%
contracting
EPS growth +82%
Y/Y
Free cash flow $-1.3M
Quant / Vol
risk profile
Very High
Volatility 243%
annualized · 1-yr
Max drawdown −81%
past year
ATR 31.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
+4% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
16% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of shares out · ▼ -96.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0 Now $0 · 16% Range high $0
vs 200-day avg -27% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NASC
Can B Corp
this stock
$758,419 -30.0% +29.0% — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $67.48B +35.5% — — 0.1%
GALDY
Galderma Group AG
 $54.01B +11.7% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $50.93B +39.9% +4.3% 99.2 2.4%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 $40.66B — — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
1
% held
0.0%
Net QoQ
0 sh
Top holder
Byrne Asset Management LLC
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
2.1K
Days to cover
1.0d
Change
-55.1K sh
View
Short Volume
Short vol %
100%
As of
Nov 10, 2026
Short Total
View
Fails to Deliver
FTD shares
5.6K
Value
$112
As of
Apr 10, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$2.2M
Net income (FY)
$-9.7M
EPS diluted
$-0.77
View
Filings
SEC Filings
Latest
NT 10-K
Filed
Mar 28, 2025
This year
0
View
Exempt Offerings
Offering
$2.8M
Filed
Dec 21, 2020
View

Performance

5D 20D 120D MTD YTD
NASC +28.7% +12.0% -25.3% +24.4% -30.0%
SPY +3.3% -1.9% +1.5% +0.2% +11.0%
vs SPY +25.5% +13.9% -26.9% +24.3% -41.0%
Key facts CIK 1509957 CUSIP 63108T105 Visit website